Home > Boards > US Listed > Medical - Healthcare > Orasure Technologies (OSUR)

$16 will be cheap, by mid May this

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
HokieHead Member Profile
Member Level 
Followed By 820
Posts 52,556
Boards Moderated 6
Alias Born 09/30/04
160x600 placeholder
OraSure Technologies Announces 2021 Annual Meeting Date GlobeNewswire Inc. - 1/8/2021 6:00:00 AM
OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 1/5/2021 6:00:00 AM
OraSure’s OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test GlobeNewswire Inc. - 12/23/2020 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/21/2020 4:46:28 PM
OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 ... GlobeNewswire Inc. - 12/21/2020 4:01:00 PM
OraSure Technologies to Commemorate World AIDS Day by Ringing NASDAQ Closing Bell GlobeNewswire Inc. - 11/30/2020 7:00:00 AM
OraSure Technologies to Present at the 2020 Evercore ISI HealthCONx Conference GlobeNewswire Inc. - 11/30/2020 7:00:00 AM
OraSure Technologies to Present at the Stephens Annual Investment Conference 2020 GlobeNewswire Inc. - 11/12/2020 7:00:00 AM
Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard Self-Collected COVID-19 Saliva Test Directly to Co... PR Newswire (US) - 11/9/2020 8:02:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:58:40 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 4:21:49 PM
OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments GlobeNewswire Inc. - 11/4/2020 4:01:00 PM
OraSure’s DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Devic... GlobeNewswire Inc. - 11/3/2020 7:00:00 AM
OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call  Wednesday, November 4, 2020, 5:00 p.m. ET GlobeNewswire Inc. - 10/21/2020 6:00:10 AM
OraSure’s OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2 GlobeNewswire Inc. - 10/19/2020 6:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/28/2020 4:59:05 PM
OraSure’s ORAcollect®·RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test GlobeNewswire Inc. - 9/24/2020 6:00:10 AM
Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics Launch Innovative Skincare Brand Using First-Ever Scientific... GlobeNewswire Inc. - 9/15/2020 12:00:10 PM
Correction to Rapid Covid-19 Tests Article (Sept. 8) Dow Jones News - 9/9/2020 1:02:00 PM
OraSure’s ORAcollect®·RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 Test GlobeNewswire Inc. - 9/3/2020 4:30:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/1/2020 6:00:36 AM
OraSure Technologies to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 8/27/2020 4:30:10 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/26/2020 4:31:44 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/10/2020 4:59:30 PM
OraSure Technologies, Inc. Announces 2020 Second Quarter Financial Results and Update on COVID-19 Testing Programs GlobeNewswire Inc. - 8/5/2020 4:01:10 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences